nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—MAOA—schizophrenia	0.195	0.266	CbGaD
Pseudoephedrine—SLC6A3—schizophrenia	0.168	0.229	CbGaD
Pseudoephedrine—TNF—schizophrenia	0.156	0.213	CbGaD
Pseudoephedrine—SLC6A4—schizophrenia	0.126	0.171	CbGaD
Pseudoephedrine—CYP2D6—schizophrenia	0.0885	0.12	CbGaD
Pseudoephedrine—IL2—blood plasma—schizophrenia	0.0063	0.0782	CbGeAlD
Pseudoephedrine—SLC6A2—locus ceruleus—schizophrenia	0.00594	0.0737	CbGeAlD
Pseudoephedrine—MAOA—locus ceruleus—schizophrenia	0.00548	0.0679	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalic ventricle—schizophrenia	0.00349	0.0433	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—schizophrenia	0.00316	0.0392	CbGeAlD
Pseudoephedrine—NFATC1—blood—schizophrenia	0.00252	0.0313	CbGeAlD
Pseudoephedrine—TNF—blood—schizophrenia	0.00241	0.0299	CbGeAlD
Pseudoephedrine—IL2—blood—schizophrenia	0.00231	0.0286	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—schizophrenia	0.00205	0.0254	CbGeAlD
Pseudoephedrine—IL2—endocrine gland—schizophrenia	0.002	0.0248	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—schizophrenia	0.00197	0.0245	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—schizophrenia	0.00193	0.0239	CbGeAlD
Pseudoephedrine—IL2—nervous system—schizophrenia	0.00187	0.0232	CbGeAlD
Pseudoephedrine—IL2—central nervous system—schizophrenia	0.0018	0.0224	CbGeAlD
Pseudoephedrine—NFATC1—brain—schizophrenia	0.00157	0.0194	CbGeAlD
Pseudoephedrine—SLC6A4—blood plasma—schizophrenia	0.00153	0.0189	CbGeAlD
Pseudoephedrine—IL2—brain—schizophrenia	0.00143	0.0178	CbGeAlD
Pseudoephedrine—CYP2D6—urine—schizophrenia	0.00141	0.0175	CbGeAlD
Pseudoephedrine—MAOA—blood plasma—schizophrenia	0.00124	0.0154	CbGeAlD
Pseudoephedrine—ADRA2A—blood plasma—schizophrenia	0.00095	0.0118	CbGeAlD
Pseudoephedrine—SLC6A3—forebrain—schizophrenia	0.000912	0.0113	CbGeAlD
Pseudoephedrine—ADRB1—forebrain—schizophrenia	0.000865	0.0107	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalon—schizophrenia	0.000839	0.0104	CbGeAlD
Pseudoephedrine—SLC6A4—forebrain—schizophrenia	0.000836	0.0104	CbGeAlD
Pseudoephedrine—ADRB1—telencephalon—schizophrenia	0.000796	0.00987	CbGeAlD
Pseudoephedrine—SLC6A4—telencephalon—schizophrenia	0.000769	0.00953	CbGeAlD
Pseudoephedrine—SLC6A2—forebrain—schizophrenia	0.000736	0.00913	CbGeAlD
Pseudoephedrine—CYP2D6—blood plasma—schizophrenia	0.000736	0.00912	CbGeAlD
Pseudoephedrine—ADRA1A—forebrain—schizophrenia	0.000684	0.00849	CbGeAlD
Pseudoephedrine—MAOA—forebrain—schizophrenia	0.000678	0.00841	CbGeAlD
Pseudoephedrine—SLC6A2—telencephalon—schizophrenia	0.000677	0.00839	CbGeAlD
Pseudoephedrine—ADRA1A—telencephalon—schizophrenia	0.000629	0.0078	CbGeAlD
Pseudoephedrine—MAOA—telencephalon—schizophrenia	0.000623	0.00773	CbGeAlD
Pseudoephedrine—SLC6A3—midbrain—schizophrenia	0.000602	0.00747	CbGeAlD
Pseudoephedrine—Ephedrine—SLC18A2—schizophrenia	0.000566	0.0872	CrCbGaD
Pseudoephedrine—SLC6A2—gonad—schizophrenia	0.000565	0.007	CbGeAlD
Pseudoephedrine—SLC6A4—blood—schizophrenia	0.000559	0.00693	CbGeAlD
Pseudoephedrine—SLC6A4—midbrain—schizophrenia	0.000552	0.00685	CbGeAlD
Pseudoephedrine—ADRA2A—forebrain—schizophrenia	0.00052	0.00645	CbGeAlD
Pseudoephedrine—ADRB1—endocrine gland—schizophrenia	0.000502	0.00622	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—schizophrenia	0.000495	0.00614	CbGeAlD
Pseudoephedrine—SLC6A4—endocrine gland—schizophrenia	0.000485	0.00601	CbGeAlD
Pseudoephedrine—ADRA2A—telencephalon—schizophrenia	0.000478	0.00593	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—schizophrenia	0.000477	0.00591	CbGeAlD
Pseudoephedrine—Etomidate—GABRB2—schizophrenia	0.000476	0.0734	CrCbGaD
Pseudoephedrine—ADRB1—nervous system—schizophrenia	0.00047	0.00583	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—schizophrenia	0.000466	0.00578	CbGeAlD
Pseudoephedrine—ADRA1A—blood—schizophrenia	0.000457	0.00567	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—schizophrenia	0.000454	0.00563	CbGeAlD
Pseudoephedrine—MAOA—blood—schizophrenia	0.000453	0.00562	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—schizophrenia	0.000452	0.00561	CbGeAlD
Pseudoephedrine—MAOA—midbrain—schizophrenia	0.000448	0.00555	CbGeAlD
Pseudoephedrine—SLC6A4—central nervous system—schizophrenia	0.000437	0.00542	CbGeAlD
Pseudoephedrine—Dextroamphetamine—SLC18A2—schizophrenia	0.000432	0.0665	CrCbGaD
Pseudoephedrine—SLC6A2—endocrine gland—schizophrenia	0.000427	0.00529	CbGeAlD
Pseudoephedrine—CYP2D6—forebrain—schizophrenia	0.000403	0.005	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—schizophrenia	0.000399	0.00496	CbGeAlD
Pseudoephedrine—ADRA2A—gonad—schizophrenia	0.000399	0.00495	CbGeAlD
Pseudoephedrine—ADRA1A—endocrine gland—schizophrenia	0.000397	0.00492	CbGeAlD
Pseudoephedrine—MAOA—endocrine gland—schizophrenia	0.000393	0.00488	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—schizophrenia	0.000385	0.00477	CbGeAlD
Pseudoephedrine—SLC6A3—brain—schizophrenia	0.000378	0.00469	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—schizophrenia	0.000371	0.00461	CbGeAlD
Pseudoephedrine—CYP2D6—telencephalon—schizophrenia	0.000371	0.0046	CbGeAlD
Pseudoephedrine—MAOA—nervous system—schizophrenia	0.000368	0.00457	CbGeAlD
Pseudoephedrine—ADRB1—brain—schizophrenia	0.000359	0.00445	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—schizophrenia	0.000358	0.00444	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—schizophrenia	0.000354	0.0044	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—schizophrenia	0.000349	0.00433	CbGeAlD
Pseudoephedrine—Amphetamine—SLC18A2—schizophrenia	0.000348	0.0536	CrCbGaD
Pseudoephedrine—ADRA2A—blood—schizophrenia	0.000348	0.00431	CbGeAlD
Pseudoephedrine—SLC6A4—brain—schizophrenia	0.000347	0.0043	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—schizophrenia	0.000346	0.0043	CbGeAlD
Pseudoephedrine—ADRA2A—midbrain—schizophrenia	0.000344	0.00426	CbGeAlD
Pseudoephedrine—Methamphetamine—SLC18A2—schizophrenia	0.000322	0.0496	CrCbGaD
Pseudoephedrine—SLC6A2—brain—schizophrenia	0.000305	0.00379	CbGeAlD
Pseudoephedrine—ADRA2A—endocrine gland—schizophrenia	0.000302	0.00374	CbGeAlD
Pseudoephedrine—ADRA1A—brain—schizophrenia	0.000284	0.00352	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—schizophrenia	0.000282	0.0035	CbGeAlD
Pseudoephedrine—MAOA—brain—schizophrenia	0.000281	0.00349	CbGeAlD
Pseudoephedrine—ADRA2A—central nervous system—schizophrenia	0.000272	0.00337	CbGeAlD
Pseudoephedrine—CYP2D6—blood—schizophrenia	0.000269	0.00334	CbGeAlD
Pseudoephedrine—ADRA2A—cerebellum—schizophrenia	0.000266	0.0033	CbGeAlD
Pseudoephedrine—Atomoxetine—HTR6—schizophrenia	0.000257	0.0396	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—MAOA—schizophrenia	0.000244	0.0376	CrCbGaD
Pseudoephedrine—CYP2D6—endocrine gland—schizophrenia	0.000234	0.0029	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—DRD1—schizophrenia	0.000222	0.0342	CrCbGaD
Pseudoephedrine—CYP2D6—nervous system—schizophrenia	0.000219	0.00271	CbGeAlD
Pseudoephedrine—Phentermine—MAOA—schizophrenia	0.000218	0.0335	CrCbGaD
Pseudoephedrine—ADRA2A—brain—schizophrenia	0.000216	0.00268	CbGeAlD
Pseudoephedrine—CYP2D6—central nervous system—schizophrenia	0.000211	0.00261	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—schizophrenia	0.000211	0.0324	CrCbGaD
Pseudoephedrine—CYP2D6—cerebellum—schizophrenia	0.000206	0.00255	CbGeAlD
Pseudoephedrine—Selegiline—MAOA—schizophrenia	0.000201	0.031	CrCbGaD
Pseudoephedrine—Phentermine—SLC6A3—schizophrenia	0.000188	0.0289	CrCbGaD
Pseudoephedrine—Dextroamphetamine—SLC6A3—schizophrenia	0.000179	0.0276	CrCbGaD
Pseudoephedrine—CYP2D6—brain—schizophrenia	0.000167	0.00207	CbGeAlD
Pseudoephedrine—Methamphetamine—MAOA—schizophrenia	0.000155	0.0239	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR1B—schizophrenia	0.000146	0.0224	CrCbGaD
Pseudoephedrine—Amphetamine—SLC6A3—schizophrenia	0.000144	0.0222	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—CYP1A2—schizophrenia	0.000143	0.0221	CrCbGaD
Pseudoephedrine—Phentermine—SLC6A4—schizophrenia	0.00014	0.0216	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A3—schizophrenia	0.000134	0.0206	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A3—schizophrenia	0.000132	0.0203	CrCbGaD
Pseudoephedrine—Phentermine—CYP1A2—schizophrenia	0.000128	0.0197	CrCbGaD
Pseudoephedrine—Benzyl alcohol—CYP1A2—schizophrenia	0.000123	0.019	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2C—schizophrenia	0.000119	0.0183	CrCbGaD
Pseudoephedrine—Selegiline—CYP1A2—schizophrenia	0.000118	0.0182	CrCbGaD
Pseudoephedrine—Amphetamine—SLC6A4—schizophrenia	0.000108	0.0166	CrCbGaD
Pseudoephedrine—Amphetamine—DRD2—schizophrenia	0.000107	0.0165	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A4—schizophrenia	0.0001	0.0154	CrCbGaD
Pseudoephedrine—Phentermine—CYP2D6—schizophrenia	9.86e-05	0.0152	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A4—schizophrenia	9.84e-05	0.0152	CrCbGaD
Pseudoephedrine—Benzyl alcohol—CYP2D6—schizophrenia	9.51e-05	0.0146	CrCbGaD
Pseudoephedrine—Dextroamphetamine—CYP2D6—schizophrenia	9.41e-05	0.0145	CrCbGaD
Pseudoephedrine—Selegiline—CYP2D6—schizophrenia	9.13e-05	0.0141	CrCbGaD
Pseudoephedrine—Amphetamine—CYP2D6—schizophrenia	7.58e-05	0.0117	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2A—schizophrenia	7.56e-05	0.0116	CrCbGaD
Pseudoephedrine—Methamphetamine—CYP2D6—schizophrenia	7.03e-05	0.0108	CrCbGaD
Pseudoephedrine—Atomoxetine—CYP2D6—schizophrenia	6.92e-05	0.0107	CrCbGaD
Pseudoephedrine—Selegiline—ABCB1—schizophrenia	6.52e-05	0.01	CrCbGaD
Pseudoephedrine—CYP2D6—Metabolism—PIP4K2A—schizophrenia	9.34e-06	5.24e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TH—schizophrenia	9.34e-06	5.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD4—schizophrenia	9.31e-06	5.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	9.29e-06	5.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL3RA—schizophrenia	9.27e-06	5.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	9.13e-06	5.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	9.09e-06	5.1e-05	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—schizophrenia	9.08e-06	5.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GAPDH—schizophrenia	9.07e-06	5.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TLE1—schizophrenia	9.04e-06	5.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRG3—schizophrenia	9.04e-06	5.08e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EP300—schizophrenia	9.02e-06	5.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CLOCK—schizophrenia	8.98e-06	5.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GFAP—schizophrenia	8.94e-06	5.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	8.94e-06	5.02e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—schizophrenia	8.91e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGA—schizophrenia	8.91e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	8.9e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CNR1—schizophrenia	8.89e-06	4.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GRM5—schizophrenia	8.84e-06	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CHRM1—schizophrenia	8.84e-06	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPH2—schizophrenia	8.76e-06	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNB2—schizophrenia	8.76e-06	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGA—schizophrenia	8.71e-06	4.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	8.71e-06	4.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	8.68e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NPY—schizophrenia	8.68e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	8.68e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD2—schizophrenia	8.68e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR7—schizophrenia	8.68e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—DPYD—schizophrenia	8.61e-06	4.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL3RA—schizophrenia	8.61e-06	4.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TLE3—schizophrenia	8.56e-06	4.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NPY—schizophrenia	8.49e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	8.49e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	8.49e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP26B1—schizophrenia	8.45e-06	4.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRG3—schizophrenia	8.4e-06	4.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TLE1—schizophrenia	8.4e-06	4.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—OXT—schizophrenia	8.37e-06	4.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR1B—schizophrenia	8.37e-06	4.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GFAP—schizophrenia	8.31e-06	4.66e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—schizophrenia	8.25e-06	4.63e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—schizophrenia	8.23e-06	4.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GRM5—schizophrenia	8.21e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR1B—schizophrenia	8.19e-06	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—OXT—schizophrenia	8.19e-06	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCK—schizophrenia	8.09e-06	4.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	8.08e-06	4.54e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EP300—schizophrenia	8.06e-06	4.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR1A—schizophrenia	8.06e-06	4.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNA1C—schizophrenia	8.01e-06	4.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TLE3—schizophrenia	7.95e-06	4.47e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—COMT—schizophrenia	7.94e-06	4.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NPS—schizophrenia	7.94e-06	4.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	7.91e-06	4.44e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTP1—schizophrenia	7.9e-06	4.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR1A—schizophrenia	7.88e-06	4.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDE4B—schizophrenia	7.88e-06	4.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3C2A—schizophrenia	7.8e-06	4.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2C—schizophrenia	7.78e-06	4.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD1—schizophrenia	7.78e-06	4.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NPS—schizophrenia	7.77e-06	4.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCKAR—schizophrenia	7.75e-06	4.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD1—schizophrenia	7.62e-06	4.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2C—schizophrenia	7.62e-06	4.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NTRK2—schizophrenia	7.57e-06	4.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD3—schizophrenia	7.54e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—schizophrenia	7.54e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPH1—schizophrenia	7.53e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCLM—schizophrenia	7.53e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADORA2A—schizophrenia	7.52e-06	4.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCK—schizophrenia	7.51e-06	4.22e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ABCB1—schizophrenia	7.48e-06	4.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NTRK2—schizophrenia	7.41e-06	4.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PLA2G4A—schizophrenia	7.39e-06	4.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD3—schizophrenia	7.38e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDE4B—schizophrenia	7.32e-06	4.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD4—schizophrenia	7.32e-06	4.11e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTM1—schizophrenia	7.26e-06	4.08e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PLA2G4A—schizophrenia	7.26e-06	4.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGA—schizophrenia	7.21e-06	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—schizophrenia	7.2e-06	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCKAR—schizophrenia	7.2e-06	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD4—schizophrenia	7.16e-06	4.02e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PRKD1—schizophrenia	7.08e-06	3.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ATP2A2—schizophrenia	7.02e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NPY—schizophrenia	7.02e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH4—schizophrenia	7.02e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP2D6—schizophrenia	7e-06	3.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SNAP25—schizophrenia	7e-06	3.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CNR1—schizophrenia	6.99e-06	3.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADORA2A—schizophrenia	6.98e-06	3.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PLA2G4A—schizophrenia	6.87e-06	3.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CNR1—schizophrenia	6.84e-06	3.84e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—schizophrenia	6.82e-06	3.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD2—schizophrenia	6.82e-06	3.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR7—schizophrenia	6.82e-06	3.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR1B—schizophrenia	6.78e-06	3.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—OXT—schizophrenia	6.78e-06	3.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGA—schizophrenia	6.7e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—schizophrenia	6.69e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD2—schizophrenia	6.67e-06	3.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR7—schizophrenia	6.67e-06	3.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—schizophrenia	6.58e-06	3.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—schizophrenia	6.54e-06	3.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NPY—schizophrenia	6.53e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH4—schizophrenia	6.53e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATP2A2—schizophrenia	6.53e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR1A—schizophrenia	6.52e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRL—schizophrenia	6.44e-06	3.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NPS—schizophrenia	6.42e-06	3.61e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTHFR—schizophrenia	6.42e-06	3.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP1A2—schizophrenia	6.33e-06	3.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRL—schizophrenia	6.3e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2C—schizophrenia	6.3e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD1—schizophrenia	6.3e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR1B—schizophrenia	6.3e-06	3.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—OXT—schizophrenia	6.3e-06	3.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TH—schizophrenia	6.24e-06	3.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK2—schizophrenia	6.13e-06	3.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD3—schizophrenia	6.1e-06	3.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—schizophrenia	6.08e-06	3.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR1A—schizophrenia	6.06e-06	3.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—S100B—schizophrenia	6e-06	3.37e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—schizophrenia	5.97e-06	3.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NPS—schizophrenia	5.97e-06	3.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD4—schizophrenia	5.92e-06	3.33e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GAPDH—schizophrenia	5.91e-06	3.32e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOA1—schizophrenia	5.91e-06	3.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—S100B—schizophrenia	5.87e-06	3.3e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CLOCK—schizophrenia	5.85e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD1—schizophrenia	5.85e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2C—schizophrenia	5.85e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—schizophrenia	5.77e-06	3.24e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—schizophrenia	5.76e-06	3.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB4—schizophrenia	5.74e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPH2—schizophrenia	5.71e-06	3.2e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNB2—schizophrenia	5.71e-06	3.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK2—schizophrenia	5.69e-06	3.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD3—schizophrenia	5.67e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CNR1—schizophrenia	5.65e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB4—schizophrenia	5.61e-06	3.15e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—DPYD—schizophrenia	5.61e-06	3.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—EP300—schizophrenia	5.61e-06	3.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR7—schizophrenia	5.52e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD2—schizophrenia	5.52e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD4—schizophrenia	5.5e-06	3.09e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—schizophrenia	5.45e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	5.4e-06	3.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—COMT—schizophrenia	5.3e-06	2.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRG1—schizophrenia	5.3e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTP1—schizophrenia	5.28e-06	2.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	5.28e-06	2.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MAOA—schizophrenia	5.27e-06	2.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CNR1—schizophrenia	5.25e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MEF2C—schizophrenia	5.25e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNA1C—schizophrenia	5.22e-06	2.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRL—schizophrenia	5.21e-06	2.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRG1—schizophrenia	5.18e-06	2.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MEF2C—schizophrenia	5.13e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR7—schizophrenia	5.13e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD2—schizophrenia	5.13e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	5.08e-06	2.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	5.07e-06	2.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ABCB1—schizophrenia	5e-06	2.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	4.96e-06	2.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB3—schizophrenia	4.96e-06	2.79e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—schizophrenia	4.87e-06	2.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—S100B—schizophrenia	4.86e-06	2.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB3—schizophrenia	4.85e-06	2.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLA2G4A—schizophrenia	4.85e-06	2.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTM1—schizophrenia	4.85e-06	2.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRL—schizophrenia	4.84e-06	2.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—schizophrenia	4.78e-06	2.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—schizophrenia	4.67e-06	2.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB4—schizophrenia	4.64e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SNAP25—schizophrenia	4.56e-06	2.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—S100B—schizophrenia	4.51e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—schizophrenia	4.44e-06	2.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOA1—schizophrenia	4.39e-06	2.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLA2G4A—schizophrenia	4.37e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—schizophrenia	4.34e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB4—schizophrenia	4.31e-06	2.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOA1—schizophrenia	4.29e-06	2.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—schizophrenia	4.29e-06	2.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRG1—schizophrenia	4.29e-06	2.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MEF2C—schizophrenia	4.25e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ESR1—schizophrenia	4.24e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ESR1—schizophrenia	4.15e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A2—schizophrenia	4.12e-06	2.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—YWHAZ—schizophrenia	4.1e-06	2.3e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TH—schizophrenia	4.07e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLA2G4A—schizophrenia	4.06e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—schizophrenia	4.02e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB3—schizophrenia	4.01e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—schizophrenia	3.99e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRG1—schizophrenia	3.98e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MEF2C—schizophrenia	3.95e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA1—schizophrenia	3.95e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—schizophrenia	3.86e-06	2.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GSK3B—schizophrenia	3.84e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—YWHAZ—schizophrenia	3.81e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GSK3B—schizophrenia	3.76e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB3—schizophrenia	3.73e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—schizophrenia	3.59e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—schizophrenia	3.59e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOA1—schizophrenia	3.55e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—schizophrenia	3.46e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—schizophrenia	3.44e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MAOA—schizophrenia	3.43e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—schizophrenia	3.43e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—schizophrenia	3.4e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—schizophrenia	3.39e-06	1.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—schizophrenia	3.34e-06	1.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOA1—schizophrenia	3.3e-06	1.85e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCB1—schizophrenia	3.26e-06	1.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—schizophrenia	3.19e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—schizophrenia	3.16e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.16e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GSK3B—schizophrenia	3.11e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GSK3B—schizophrenia	2.89e-06	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	2.85e-06	1.6e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—schizophrenia	2.79e-06	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	2.79e-06	1.57e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—schizophrenia	2.6e-06	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—schizophrenia	2.59e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA1—schizophrenia	2.57e-06	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—schizophrenia	2.53e-06	1.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—schizophrenia	2.53e-06	1.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—schizophrenia	2.47e-06	1.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—schizophrenia	2.31e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—schizophrenia	2.27e-06	1.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—schizophrenia	2.14e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—schizophrenia	2.09e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—schizophrenia	2.06e-06	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—schizophrenia	2.05e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—schizophrenia	1.95e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—schizophrenia	1.9e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—schizophrenia	1.81e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—schizophrenia	1.77e-06	9.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—schizophrenia	1.53e-06	8.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—schizophrenia	1.5e-06	8.4e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—schizophrenia	1.48e-06	8.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—schizophrenia	1.46e-06	8.23e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—schizophrenia	1.37e-06	7.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—schizophrenia	1.36e-06	7.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—schizophrenia	1.24e-06	6.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—schizophrenia	1.15e-06	6.45e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—schizophrenia	8.96e-07	5.03e-06	CbGpPWpGaD
